Učitavanje...
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine
[Image: see text] Biomarker-driven drug selection plays a central role in cancer drug discovery and development, and in diagnostic strategies to improve the use of traditional chemotherapeutic drugs. DNA-modifying anticancer drugs are still used as first line medication, but drawbacks such as resist...
Spremljeno u:
| Izdano u: | Chem Res Toxicol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Chemical
Society
2016
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379252/ https://ncbi.nlm.nih.gov/pubmed/27936622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.chemrestox.6b00380 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|